Literature DB >> 9349462

High and low efficiency neutralization epitopes on the haemagglutinin of type A influenza virus.

D J Schofield1, J R Stephenson, N J Dimmock.   

Abstract

The relationship between the efficiency of the neutralization process and the affinity of five monoclonal IgG antibodies specific for the haemagglutinin of type A influenza virus has been investigated by determining their neutralization rate constants (Kneut.) and affinities (Kdissoc.). We addressed the hypothesis that if antibody affinity alone determined the efficiency of neutralization, then the Kneut.:Kdissoc. ratio would be the same for all antibodies. However, we found that the Kneut.:Kdissoc. ratio varied by up to 125-fold, suggesting that properties unique to the epitope are of major importance in determining the efficiency of neutralization. These data suggest that vaccines should preferentially stimulate antibodies to epitopes that mediate the most efficient neutralization, and that a high Kdissoc. should be an important but secondary consideration.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9349462     DOI: 10.1099/0022-1317-78-10-2441

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  7 in total

1.  Differential neutralization efficiency of hemagglutinin epitopes, antibody interference, and the design of influenza vaccines.

Authors:  Wilfred Ndifon; Ned S Wingreen; Simon A Levin
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-13       Impact factor: 11.205

Review 2.  To dream the impossible dream: universal influenza vaccination.

Authors:  Jonathan W Yewdell
Journal:  Curr Opin Virol       Date:  2013-07-05       Impact factor: 7.090

Review 3.  Structural basis of influenza virus neutralization.

Authors:  Thomas Han; Wayne A Marasco
Journal:  Ann N Y Acad Sci       Date:  2011-01-11       Impact factor: 5.691

4.  Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M.

Authors:  P N Nyambi; H A Mbah; S Burda; C Williams; M K Gorny; A Nádas; S Zolla-Pazner
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

5.  Complement-mediated enhancement of antibody function for neutralization of pseudotype virus containing hepatitis C virus E2 chimeric glycoprotein.

Authors:  Keith Meyer; Arnab Basu; Craig T Przysiecki; L Martin Lagging; Adrian M Di Bisceglie; Anthony J Conley; Ranjit Ray
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

6.  Prophylactic and therapeutic activity of fully human monoclonal antibodies directed against influenza A M2 protein.

Authors:  Roger R Beerli; Monika Bauer; Nicole Schmitz; Regula B Buser; Myriam Gwerder; Simone Muntwiler; Wolfgang A Renner; Philippe Saudan; Martin F Bachmann
Journal:  Virol J       Date:  2009-12-21       Impact factor: 4.099

Review 7.  Variation and infectivity neutralization in influenza.

Authors:  Marcel Knossow; John J Skehel
Journal:  Immunology       Date:  2006-09       Impact factor: 7.397

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.